Seminars in Oncology
Volume 34, Supplement 1 , Pages S25-S30, April 2007

Treatment of Advanced Pancreatic Cancer

  • Michel Ducreux

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Michel Ducreux, MD, PhD, Institut Gustave Roussy, 39 rue Camille Desmoulins, Villejuif 94805, France.
    • Dr Ducreux has received research grant support from Pfizer, Roche, and Sanofi-Aventis, and has received honoraria or consulting fees from Amgen, Merck Lipha Santé, Pfizer, Roche, and Sanofi-Aventis.
  • ,
  • Valérie Boige

      Affiliations

    • Dr Boige has received research grant support and honoraria or consulting fees from Roche and Sanofi-Aventis.
  • ,
  • David Malka

      Affiliations

    • Dr Malka has received research grant support from Merck Lipha Santé, Pfizer, Roche, and Sanofi-Aventis and has received consulting fees or honoraria from Merck Lipha Santé, Pfizer, Roche, and Sanofi-Aventis.

Gastroenterology Unit, Institut Gustave Roussy, Villejuif, France.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0093-7754(07)00023-1

doi:10.1053/j.seminoncol.2007.01.006

Seminars in Oncology
Volume 34, Supplement 1 , Pages S25-S30, April 2007